Company / Current Assets per Share
INOVIO PHARMACEUTICALS, INC. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$1.69
FY2025
5-year range
$1.45 / $7.26
FY2021-FY2025
Trend
-60.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 10 years, ranging from $0.97 in FY2019 to $7.26 in FY2023.
Based on SEC 10-K filings.
1.69 in FY2025 with a 5-year CAGR of -18.3%.
Declined from $7.26 to $1.69 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- -18.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 60.6% year-over-year.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.69 | -60.6% |
| FY2024 | $4.29 | -40.9% |
| FY2023 | $7.26 | +400.6% |
| FY2022 | $1.45 | -39.6% |
| FY2021 | $2.40 | -48.4% |
| FY2020 | $4.65 | +379.8% |
| FY2019 | $0.97 | -0.3% |
| FY2018 | $0.97 | -48.0% |
| FY2017 | $1.87 | +8.3% |
| FY2016 | $1.73 | -39.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026